{"id":"https://openalex.org/W1617280686","doi":"https://doi.org/10.1016/s0151-9638(05)79281-4","title":"Aggravation d\u2019un lupus \u00e9ryth\u00e9mateux subaigu sous infliximab","display_name":"Aggravation d\u2019un lupus \u00e9ryth\u00e9mateux subaigu sous infliximab","publication_year":2005,"publication_date":"2005-04-01","ids":{"openalex":"https://openalex.org/W1617280686","doi":"https://doi.org/10.1016/s0151-9638(05)79281-4","mag":"1617280686","pmid":"https://pubmed.ncbi.nlm.nih.gov/15886563"},"language":"fr","primary_location":{"id":"doi:10.1016/s0151-9638(05)79281-4","doi":"https://doi.org/10.1016/s0151-9638(05)79281-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0151-9638(05)79281-4","pdf_url":null,"source":{"id":"https://openalex.org/S41786655","display_name":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","issn_l":"0151-9638","issn":["0151-9638","2214-5451"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000338714","display_name":"C.-M. Vabre-Latre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C.-M. Vabre-Latre","raw_affiliation_strings":["Service de Dermatologie, CHU Purpan, Toulouse"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Dermatologie, CHU Purpan, Toulouse","institution_ids":["https://openalex.org/I4210138343"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049791540","display_name":"Paule Bayle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"P. Bayle","raw_affiliation_strings":["Service de Dermatologie, CHU Purpan, Toulouse"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Dermatologie, CHU Purpan, Toulouse","institution_ids":["https://openalex.org/I4210138343"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113713097","display_name":"M.C. Marguery","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M.-C. Marguery","raw_affiliation_strings":["Service de Dermatologie, CHU Purpan, Toulouse"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Dermatologie, CHU Purpan, Toulouse","institution_ids":["https://openalex.org/I4210138343"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087605650","display_name":"Agn\u00e8s Gadroy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Gadroy","raw_affiliation_strings":["Service de Dermatologie, CHU Purpan, Toulouse"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Dermatologie, CHU Purpan, Toulouse","institution_ids":["https://openalex.org/I4210138343"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Durand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123497","display_name":"H\u00f4pital Rangueil","ror":"https://ror.org/034zn5b34","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"D. Durand","raw_affiliation_strings":["Service de N\u00e9phrologie, CHU Rangueil, Toulouse"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de N\u00e9phrologie, CHU Rangueil, Toulouse","institution_ids":["https://openalex.org/I4210123497"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110263345","display_name":"J Bazex","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J. Bazex","raw_affiliation_strings":["Service de Dermatologie, CHU Purpan, Toulouse"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Dermatologie, CHU Purpan, Toulouse","institution_ids":["https://openalex.org/I4210138343"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5049791540"],"corresponding_institution_ids":["https://openalex.org/I4210138343"],"apc_list":{"value":2040,"currency":"USD","value_usd":2040},"apc_paid":null,"fwci":0.8843,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.73085013,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"132","issue":"4","first_page":"349","last_page":"353"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/subacute-cutaneous-lupus-erythematosus","display_name":"subacute cutaneous lupus erythematosus","score":0.925000011920929},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.8180000185966492},{"id":"https://openalex.org/keywords/drug-induced-lupus-erythematosus","display_name":"drug-induced lupus","score":0.8389999866485596},{"id":"https://openalex.org/keywords/anti-tnf-therapy","display_name":"anti-TNF therapy","score":0.843999981880188},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9129999876022339},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.8130000233650208},{"id":"https://openalex.org/keywords/autoimmune-disease-flare","display_name":"autoimmune disease flare","score":0.6610000133514404},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8299999833106995}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9458900690078735},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.8540937304496765},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.7275214195251465},{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.5852037072181702},{"id":"https://openalex.org/C2775915377","wikidata":"https://www.wikidata.org/wiki/Q188297","display_name":"Lupus erythematosus","level":3,"score":0.4719471335411072},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4071204662322998},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.3893272578716278},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35620343685150146},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3404580056667328},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23869678378105164},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.13753312826156616},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.05866000056266785}],"mesh":[{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008178","descriptor_name":"Lupus Erythematosus, Cutaneous","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0151-9638(05)79281-4","doi":"https://doi.org/10.1016/s0151-9638(05)79281-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0151-9638(05)79281-4","pdf_url":null,"source":{"id":"https://openalex.org/S41786655","display_name":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","issn_l":"0151-9638","issn":["0151-9638","2214-5451"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","raw_type":"journal-article"},{"id":"pmid:15886563","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15886563","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annales de dermatologie et de venereologie","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1968908522","https://openalex.org/W1992028361","https://openalex.org/W1995230659","https://openalex.org/W2001588815","https://openalex.org/W2006196505","https://openalex.org/W2007050875","https://openalex.org/W2007830806","https://openalex.org/W2010753554","https://openalex.org/W2024608463","https://openalex.org/W2026701360","https://openalex.org/W2094313417","https://openalex.org/W2108658225","https://openalex.org/W2139978270","https://openalex.org/W2158329969","https://openalex.org/W2164368961","https://openalex.org/W2168626353","https://openalex.org/W2316489280"],"related_works":["https://openalex.org/W2012597492","https://openalex.org/W1656234424","https://openalex.org/W2414595371","https://openalex.org/W1997286906","https://openalex.org/W2316489280","https://openalex.org/W2006384629","https://openalex.org/W2131114953","https://openalex.org/W7120720472","https://openalex.org/W2006196505","https://openalex.org/W7001082661"],"abstract_inverted_index":null,"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}